CLINICAL_TRIALS
trial_result
· 2021-12-06
Clinical Trial Update: Piloting Treatment With Intranasal Oxytocin in Phelan-McDermid Syndrome [Phase 2]
Summary
Phase 2 trial updating intranasal oxytocin treatment in Phelan-McDermid Syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Alexander Kolevzon | Conditions: Phelan-McDermid Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2021-12-06